Actively Recruiting
Assessing Effect of Spinal Cord Stimulation on Pain and Quality of Life With Chemotherapy-Induced Peripheral Neuropathy
Led by Mayo Clinic · Updated on 2026-02-02
20
Participants Needed
1
Research Sites
261 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study examines how spinal cord stimulation (SCS) affects pain level and quality of life in patients experiencing chemotherapy-induced peripheral neuropathy (CIPN). CIPN is a nerve problem and one of the potential side effects of chemotherapy that causes pain, numbness, tingling, swelling, or muscle weakness in different parts of the body. CIPN usually begins in the hands or feet and gets worse over time. SCS is a type of therapy that has proven to be effective in treating numerous non-malignant pain disorders including failed back surgery syndrome, refractory angina, limb ischemia, complex regional pain syndrome, and diabetic peripheral neuropathy. SCS may also be useful in patients with CIPN. This study evaluates how SCS affects pain and quality of life in patients undergoing spinal cord stimulation for CIPN.
CONDITIONS
Official Title
Assessing Effect of Spinal Cord Stimulation on Pain and Quality of Life With Chemotherapy-Induced Peripheral Neuropathy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients aged 18 years or older with a clinical diagnosis of chemotherapy-induced peripheral neuropathy for more than six months after stopping chemotherapy
- Average pain intensity of 5 or higher on an 11-point numeric rating scale in the lower extremities at enrollment
- Have tried and failed conventional medication management with at least two neuropathic pain medications
- Have electrophysiological evidence of length-dependent peripheral neuropathy
- Completed a 10-kHz spinal cord stimulator trial for CIPN with at least 75% pain reduction
- Stable neurological status
- On a stable pain medication regimen
- Suitable candidate for surgical procedures required by this study
- Able to read and understand English questionnaires and provide informed consent in English
- Willing and able to complete all study procedures and visits
You will not qualify if you...
- Patient refusal to participate in the study
- Presence of lower limb mononeuropathy
- History of lower limb amputation or ulceration
- Presence of another painful condition unrelated to CIPN and not treated in this study
- Body mass index (BMI) of 40 or higher
- Omeprazole dose over 120 mg
- Progressive neurological diseases such as multiple sclerosis or severe spinal conditions
- Certain comorbidities including coagulation or bleeding disorders and severe cardiac or pulmonary disease
- Receiving other interventional procedures unrelated to spinal cord stimulation for limb pain
- Active metastatic or untreated local malignant neoplasm unless deemed in remission
- Life expectancy less than one year
- Untreated addiction or dependency to medications, alcohol, or illicit drugs
- Active, disruptive, or unstable psychological or psychiatric disorders
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905
Actively Recruiting
Research Team
C
Clinical Trials Referral Office
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here